Articles for category: Most Popular

The whipping post

Most Popular

Insightful Outlook on Wolfspeed for Investors Intriguing Developments in the World of Wolfspeed

Investors with substantial capital have taken a pessimistic stance on Wolfspeed WOLF. It’s a noteworthy observation for retail traders to bear in mind. Today’s revelation was made public through options trading data that we diligently monitor here at Benzinga. Whether these market players are institutions or affluent individuals remains a mystery. Nonetheless, significant activity in ...

The whipping post

Most Popular

Is Broadcom Poised to Enter the Elite “Magnificent Seven” Tech Stocks? | Financial Analysis A New Contender in the Tech Stock Arena

Seven of the world’s top technology stocks have recently been dubbed “The Magnificent Seven.” What sets them apart from the pack? Well, once upon a time, they were known as the FAANG stocks until the tech landscape shifted, welcoming Nvidia and Microsoft while bidding adieu to Netflix. So which underdog is eyeing a spot among ...

The whipping post

Most Popular

Auto Industry Dynamics: Fined and Rewarded

China’s vehicle sales experienced a sharp decline of approximately 27% in February, with 1.2 million units sold, as disclosed by the China Association of Automobile Manufacturers (“CAAM”). This plummet has been chiefly attributed to reduced production during the eight-day Spring Festival holiday. Auto Players in the Spotlight In the world of wheels, Group 1 Automotive, ...

The whipping post

Most Popular

Core & Main: Q4 Results Spark 7% Gain Amidst Market Volatility Core & Main: Q4 Results Spark 7% Gain Amidst Market Volatility

Market Overview U.S. stocks traded mixed midway through trading, with the Dow Jones gaining more than 200 points on Tuesday. The Dow traded up 0.54% to 39,001.22 while the NASDAQ fell 0.34% to 16,048.51. The S&P 500 also rose, gaining 0.02% to 5,150.45. Sector Performance Energy shares rose by 0.7% on Tuesday, while communication services ...

The whipping post

Most Popular

CrowdStrike, PACCAR, Leidos Holdings And More On CNBC's 'Final Trades'

Cybersecurity Giants and Industrial Stocks: A Market Overview The Buzz on CNBC’s ‘Final Trades’ Shannon Saccocia of NB Private Wealth highlighted the iShares S&P GSCI Commodity-Indexed Trust (GSG), emphasizing China’s potential impact on the commodity market. Stephen Weiss of Short Hills Capital Partners endorsed Leidos Holdings, Inc. (LDOS) in his closing trade, following the company’s ...

The whipping post

Most Popular

Analysis Unveiled: Nvidia’s Dominance Continues to Soar After Blackwell GPU Announcement Analysis Unveiled: Nvidia’s Dominance Continues to Soar After Blackwell GPU Announcement

March 18 witnessed a monumental event for Nvidia Corp (NVDA). At the GPU Technology Conference (GTC 2024), the company showcased groundbreaking updates and advancements in accelerated computing. Although the event failed to significantly impact Nvidia’s stock on Monday, with a mere 0.70% increase during trading hours, it did experience a 1.42% dip in post-market trading. ...

The whipping post

Most Popular

The Evolution of Microgrids: Driving Corporate Sustainability with Correlate Energy The Evolution of Microgrids: Driving Corporate Sustainability with Correlate Energy

In this era of swiftly evolving energy dynamics, the ascent of clean energy stands beyond dispute. The past decade has witnessed a remarkable proliferation of renewable energy technologies, with microgrids emerging as a frontrunner. A microgrid epitomizes a miniature power grid catering to a confined locality, typically comprising renewable energy sources such as solar panels ...

The whipping post

Most Popular

CENTOGENE and Takeda: A Diagnostic Collaboration Extension CENTOGENE and Takeda: A Diagnostic Collaboration Extension

rafal_olechowski Centogene (NASDAQ:CNTG) recently announced the extension of its collaboration with Takeda Pharmaceutical (NYSE:TAK) to provide diagnostic solutions for patients with Lysosomal Storage Disorders (LSDs), a collection of inherited metabolic conditions. Under the agreement, the German biotech company will continue to offer its testing services to Takeda for the early and efficient diagnosis of patients ...